Cargando…

SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes

OBJECTIVE: Based on the whole-body energy metabolism and insulin action, the difference between increased excretion of carbohydrate in urine by SGLT2i and reduced same amount of oral carbohydrate intake are scarce. This study aimed to compare the effect of carbohydrate availability with reduced oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Igarashi, Hiroyuki, Uchino, Hiroshi, Kanaguchi, Momoko, Hisanaga, Kaori, Sato, Genki, Yoshikawa, Fukumi, Furuta, Masashi, Washizawa, Naohiro, Usui, Shuki, Miyagi, Masahiko, Hirose, Takahisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940379/
https://www.ncbi.nlm.nih.gov/pubmed/36804863
http://dx.doi.org/10.1186/s13098-023-00990-6
_version_ 1784891064948097024
author Igarashi, Hiroyuki
Uchino, Hiroshi
Kanaguchi, Momoko
Hisanaga, Kaori
Sato, Genki
Yoshikawa, Fukumi
Furuta, Masashi
Washizawa, Naohiro
Usui, Shuki
Miyagi, Masahiko
Hirose, Takahisa
author_facet Igarashi, Hiroyuki
Uchino, Hiroshi
Kanaguchi, Momoko
Hisanaga, Kaori
Sato, Genki
Yoshikawa, Fukumi
Furuta, Masashi
Washizawa, Naohiro
Usui, Shuki
Miyagi, Masahiko
Hirose, Takahisa
author_sort Igarashi, Hiroyuki
collection PubMed
description OBJECTIVE: Based on the whole-body energy metabolism and insulin action, the difference between increased excretion of carbohydrate in urine by SGLT2i and reduced same amount of oral carbohydrate intake are scarce. This study aimed to compare the effect of carbohydrate availability with reduced oral intake (carbohydrate-restricted isocaloric diet: CRIC diet) or lost in urine, as urinary glucosuria on sodium/glucose cotransporter-2 inhibitor (SGLT2i) treatment, focus on the insulin requirement and the macronutrient oxidation within insulin treated type 2 diabetes. METHODS: This is randomized 3-arm open-label prospective study. Subjects treated with titrated basal-bolus insulin regimen subsequent to three diet regimens, control diet (CON), administration of canagliflozin 100 mg/day to CON (SGLT2i), or CRIC diet, with a week admission to the endocrinology ward followed by 12 weeks outpatients’ management. The main outcome measures including the total insulin dose (TID) required to achieve euglycemia, fasting and postprandial energy expenditure (EE) and respiratory quotient (RQ) at 1-week and 12-week. RESULTS: We enrolled 23 patients with type 2 diabetes (male/female: 14/9, age: 53.6 ± 14.2 years, body mass index: 26.9 ± 4.8 kg/m(2), HbA1c: 12.5 ± 1.6%). The TID was similar with CON and SGLT2i at both 1 and 12-weeks. Although comparable net carbohydrate availability in SGLT2i and CRIC groups, the TID was significantly higher in the CRIC (p = 0.02) compare to the SGLT2i at both 1 and 12-weeks. Fasting EE was similar in all groups, postprandial EE was significantly elevated in the SGLT2i and CRIC groups compared to the CON group (p = 0.03 and 0.04). Compare to the CON, lower basal fasting RQ (p = 0.049) and decreased delta-RQ (postprandial RQ/fasting RQ) indicated continuous lipid substrate utilization in the SGLT2i (p = 0.04) and CRIC (p = 0.03) groups. CONCLUSION: The CRIC diet resulted in a similar fasting and postprandial EE and substrate oxidation compared to the SGLT2i. The increased insulin requirement in the CRIC diet indicates that a relatively highly lipid and protein consumption, compared to the SGLT2i and CON, may influence insulin requirement. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-023-00990-6.
format Online
Article
Text
id pubmed-9940379
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99403792023-02-21 SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes Igarashi, Hiroyuki Uchino, Hiroshi Kanaguchi, Momoko Hisanaga, Kaori Sato, Genki Yoshikawa, Fukumi Furuta, Masashi Washizawa, Naohiro Usui, Shuki Miyagi, Masahiko Hirose, Takahisa Diabetol Metab Syndr Research OBJECTIVE: Based on the whole-body energy metabolism and insulin action, the difference between increased excretion of carbohydrate in urine by SGLT2i and reduced same amount of oral carbohydrate intake are scarce. This study aimed to compare the effect of carbohydrate availability with reduced oral intake (carbohydrate-restricted isocaloric diet: CRIC diet) or lost in urine, as urinary glucosuria on sodium/glucose cotransporter-2 inhibitor (SGLT2i) treatment, focus on the insulin requirement and the macronutrient oxidation within insulin treated type 2 diabetes. METHODS: This is randomized 3-arm open-label prospective study. Subjects treated with titrated basal-bolus insulin regimen subsequent to three diet regimens, control diet (CON), administration of canagliflozin 100 mg/day to CON (SGLT2i), or CRIC diet, with a week admission to the endocrinology ward followed by 12 weeks outpatients’ management. The main outcome measures including the total insulin dose (TID) required to achieve euglycemia, fasting and postprandial energy expenditure (EE) and respiratory quotient (RQ) at 1-week and 12-week. RESULTS: We enrolled 23 patients with type 2 diabetes (male/female: 14/9, age: 53.6 ± 14.2 years, body mass index: 26.9 ± 4.8 kg/m(2), HbA1c: 12.5 ± 1.6%). The TID was similar with CON and SGLT2i at both 1 and 12-weeks. Although comparable net carbohydrate availability in SGLT2i and CRIC groups, the TID was significantly higher in the CRIC (p = 0.02) compare to the SGLT2i at both 1 and 12-weeks. Fasting EE was similar in all groups, postprandial EE was significantly elevated in the SGLT2i and CRIC groups compared to the CON group (p = 0.03 and 0.04). Compare to the CON, lower basal fasting RQ (p = 0.049) and decreased delta-RQ (postprandial RQ/fasting RQ) indicated continuous lipid substrate utilization in the SGLT2i (p = 0.04) and CRIC (p = 0.03) groups. CONCLUSION: The CRIC diet resulted in a similar fasting and postprandial EE and substrate oxidation compared to the SGLT2i. The increased insulin requirement in the CRIC diet indicates that a relatively highly lipid and protein consumption, compared to the SGLT2i and CON, may influence insulin requirement. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-023-00990-6. BioMed Central 2023-02-19 /pmc/articles/PMC9940379/ /pubmed/36804863 http://dx.doi.org/10.1186/s13098-023-00990-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Igarashi, Hiroyuki
Uchino, Hiroshi
Kanaguchi, Momoko
Hisanaga, Kaori
Sato, Genki
Yoshikawa, Fukumi
Furuta, Masashi
Washizawa, Naohiro
Usui, Shuki
Miyagi, Masahiko
Hirose, Takahisa
SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes
title SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes
title_full SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes
title_fullStr SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes
title_full_unstemmed SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes
title_short SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes
title_sort sglt2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940379/
https://www.ncbi.nlm.nih.gov/pubmed/36804863
http://dx.doi.org/10.1186/s13098-023-00990-6
work_keys_str_mv AT igarashihiroyuki sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes
AT uchinohiroshi sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes
AT kanaguchimomoko sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes
AT hisanagakaori sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes
AT satogenki sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes
AT yoshikawafukumi sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes
AT furutamasashi sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes
AT washizawanaohiro sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes
AT usuishuki sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes
AT miyagimasahiko sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes
AT hirosetakahisa sglt2inhibitorversuscarbohydraterestrictedisocaloricdietreprogrammingsubstrateoxidationintype2diabetes